Jade Biosciences annual total assets
2020
2021
2022
2023
2024
2025
Jade Biosciences Total Assets Growth & History (JBIO)
Jade Biosciences's total assets was $349.8M for fiscal 2025.
View full Jade Biosciences company overviewJade Biosciences annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $349.8M | $277.0M | +380.48% |
| 2024 | 2024-12-31 | $72.8M | −$54.6M | −42.87% |
| 2023 | 2023-12-31 | $127.4M | −$7.9M | −5.83% |
| 2022 | 2022-12-31 | $135.3M | −$40.1M | −22.85% |
| 2021 | 2021-12-31 | $175.4M | $170.6M | +3619.26% |
| 2020 | 2020-12-31 | $4.7M | — | — |
Jade Biosciences quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $472.1M | $248.1M | +110.79% |
| Q1 2026 | 2026-03-31 | $319.4M | $241.9M | +312.00% |
| Q4 2025 | 2025-12-31 | $349.8M | $277.0M | +380.48% |
| Q3 2025 | 2025-09-30 | $202.4M | $111.5M | +122.57% |
| Q2 2025 | 2025-06-30 | $224.0M | $112.3M | +100.52% |
| Q1 2025 | 2025-03-31 | $77.5M | −$29.3M | −27.42% |
| Q4 2024 | 2024-12-31 | $72.8M | −$54.6M | −42.87% |
| Q3 2024 | 2024-09-30 | $91.0M | −$49.9M | −35.43% |
| Q2 2024 | 2024-06-30 | $111.7M | −$44.1M | −28.29% |
| Q1 2024 | 2024-03-31 | $106.8M | −$17.6M | −14.13% |
| Q4 2023 | 2023-12-31 | $127.4M | −$7.9M | −5.83% |
| Q3 2023 | 2023-09-30 | $140.9M | −$6.8M | −4.59% |
| Q2 2023 | 2023-06-30 | $155.8M | $71,000 | +0.05% |
| Q1 2023 | 2023-03-31 | $124.4M | −$42.6M | −25.51% |
| Q4 2022 | 2022-12-31 | $135.3M | −$40.1M | −22.85% |
| Q3 2022 | 2022-09-30 | $147.7M | −$36.5M | −19.81% |
| Q2 2022 | 2022-06-30 | $155.7M | $93.3M | +149.36% |
| Q1 2022 | 2022-03-31 | $167.0M | — | — |
| Q4 2021 | 2021-12-31 | $175.4M | $170.6M | +3619.26% |
| Q3 2021 | 2021-09-30 | $184.1M | — | — |
| Q2 2021 | 2021-06-30 | $62.4M | — | — |
| Q4 2020 | 2020-12-31 | $4.7M | — | — |
Jade Biosciences total assets trends
Over the last five fiscal years, Jade Biosciences's total assets increased from $4.7M to $349.8M, a change of $345.1M. The latest reported quarter, Q2 2026, shows $472.1M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Jade Biosciences source filings ↗